Abstract
Abstract Chlamydia abortus (C. abortus) is an obligate intracellular pathogen that causes abortion in pigs and poses a zoonotic risk in pregnant women. Currently available attenuated and inactivated vaccines show marginal protective efficacy underlining the need for the development of effective vaccines. Recombinant proteins expressed on gram negative bacterial envelopes are known to induce protective immunity (Th1) without the need of any additional adjuvant. Pmp18D is a member of polymorphic outer membrane protein family of C.abortus. The PmpD protein of C. abortus is expressed throughout the chlamydial developmental cycle. Pmp protein family members are known to exhibit higher immunogenicity. In this study an evaluation of immune responses to Vibrio cholerae ghosts expressing Pmp18D(rVCG) was done in comparison to rPmp18D codelivered with either Flt3L or CpG. Mice were immunized 3 times intranasally 2 weeks apart .By day 14 post last immunization, the rVCG vaccine elicited significantly higher levels of antigen-specific IgG2a and IgA antibodies both in serum and in vaginal washes. Proliferative responses of mucosal (genital tract) as well as splenic (systemic) T cells were significantly higher in mice receiving rVCG vaccine.These results indicate that the rVCG-Pmp18D vaccine is capable of inducing antigen-specific cellular and humoral immune responses that may provide protective immunity against a live challenge infection with C.abortus.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
